Arkolith/Insider Trading/PBAX/Form 4

Ehrlich Christopher B

CEO and Secretary, Director, 10% OwnerPHOENIX BIOTECH ACQUISITION CORP. (PBAX) · full profile →Form 4 · filed Oct 12, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 8, 2021Other(J)37K$10.00$367K700K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 8, 2021Other(J)83K——4.6M
Oct 8, 2021Other(J)18K—$0350K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-039941) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML